Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dieter Glebe

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Ebiomedicine|August 4, 2016
Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B VaccineWolfram H Gerlich, Dieter Glebe
Journal of Virology|May 16, 2006
Lipid-mediated introduction of hepatitis B virus capsids into nonsusceptible cells allows highly efficient replication and facilitates the study of early infection eventsBirgit Rabe, Dieter Glebe, Michael Kann
Methods in Molecular Medicine|February 6, 2004
Quantitative assay of hepatitis B surface antigen in serum or plasma using laurell electrophoresisWolfram H Gerlich, Ulrike Wend, Dieter Glebe
The New England Journal of Medicine|July 31, 2014
More on hepatitis B virus rtI233V mutation and resistance to adefovirAndreas Geipel, Dieter Glebe, Wolfram H Gerlich
Cellular Microbiology|December 19, 2007
Role of glycosaminoglycans for binding and infection of hepatitis B virusCorinna M Leistner, Stefanie Gruen-Bernhard, Dieter Glebe
Antiviral Research|November 9, 2020
HBV evolution and genetic variability: Impact on prevention, treatment and development of antiviralsDieter Glebe, Nora Goldmann, Chris Lauber, et al.
The New England Journal of Medicine|April 25, 2014
Hepatitis B virus rtI233V mutation and resistance to adefovirAndreas Geipel, Dieter Glebe, Hans Will, et al.
Emerging Microbes & Infections|November 12, 2021
Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modificationAnastasiya Kostyusheva, Sergey Brezgin, Dieter Glebe, et al.
BMC Infectious Diseases|July 20, 2013
Molecular characterization of hepatitis B virus in liver disease patients and asymptomatic carriers of the virus in SudanMukhlid Yousif, Hatim Mudawi, Sahar Bakhiet, et al.
Virus Genes|February 7, 2020
Peculiarities in the designations of hepatitis B virus genes, their products, and their antigenic specificities: a potential source of misunderstandingsWolfram H Gerlich, Dieter Glebe, Anna Kramvis, et al.
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Ebiomedicine|August 4, 2016
Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B VaccineWolfram H Gerlich, Dieter Glebe
Journal of Virology|May 16, 2006
Lipid-mediated introduction of hepatitis B virus capsids into nonsusceptible cells allows highly efficient replication and facilitates the study of early infection eventsBirgit Rabe, Dieter Glebe, Michael Kann
Methods in Molecular Medicine|February 6, 2004
Quantitative assay of hepatitis B surface antigen in serum or plasma using laurell electrophoresisWolfram H Gerlich, Ulrike Wend, Dieter Glebe
The New England Journal of Medicine|July 31, 2014
More on hepatitis B virus rtI233V mutation and resistance to adefovirAndreas Geipel, Dieter Glebe, Wolfram H Gerlich
Cellular Microbiology|December 19, 2007
Role of glycosaminoglycans for binding and infection of hepatitis B virusCorinna M Leistner, Stefanie Gruen-Bernhard, Dieter Glebe
Antiviral Research|November 9, 2020
HBV evolution and genetic variability: Impact on prevention, treatment and development of antiviralsDieter Glebe, Nora Goldmann, Chris Lauber, et al.
The New England Journal of Medicine|April 25, 2014
Hepatitis B virus rtI233V mutation and resistance to adefovirAndreas Geipel, Dieter Glebe, Hans Will, et al.
Emerging Microbes & Infections|November 12, 2021
Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modificationAnastasiya Kostyusheva, Sergey Brezgin, Dieter Glebe, et al.
BMC Infectious Diseases|July 20, 2013
Molecular characterization of hepatitis B virus in liver disease patients and asymptomatic carriers of the virus in SudanMukhlid Yousif, Hatim Mudawi, Sahar Bakhiet, et al.
Virus Genes|February 7, 2020
Peculiarities in the designations of hepatitis B virus genes, their products, and their antigenic specificities: a potential source of misunderstandingsWolfram H Gerlich, Dieter Glebe, Anna Kramvis, et al.
Pageof 12